Trump creëert een 'gevaarlijke situatie' door een onbewezen coronavirusbehandeling te promoten, volgens een expert op het gebied van verkeerde informati

Trump creëert een 'gevaarlijke situatie' door een onbewezen coronavirusbehandeling te promoten, volgens een expert op het gebied van verkeerde informati

mei 7, 2020 0 Door admin

Translating…


CBD Olie kan helpen bij artrose. Lees hoe op MHBioShop.com


Huile de CBD peut aider avec l’arthrose. Visite HuileCBD.be


 

A pharmacy worker shows a box of Plaquenil, or hydroxychloroquine in Paris.
A pharmacy worker shows a box of Plaquenil, or hydroxychloroquine in Paris.

Chesnot/Getty Images

  • President Donald Trump’s promotion of an unproven coronavirus treatment is creating a “dangerous situation,” according to misinformation expert Lisa Fazio.

  • Trump has repeatedly talked up the potential benefits of anti-malaria drug chloroquine and the more widely used hydroxychloroquine despite a lack of clinical evidence showing that either are effective against COVID-19.

  • His enthusiasm has helped fuel a surge in demand that’s led to a shortage, making it hard for people who rely on the drugs to treat non-coronavirus conditions to fill their prescriptions.

  • Trump’s endorsement is particularly worrisome given the amount of misinformation already surrounding the coronavirus, Fazio told Business Insider.

  • Visit Business Insider’s homepage for more stories.

President Donald Trump’s enthusiasm for an unproven coronavirus treatment is putting people who already rely on the drug at risk, said Liza Fazio, a professor of psychology at Vanderbilt University.

“It’s a dangerous situation to have anyone be promoting something that we don’t yet know if it’s safe for useful,” Fazio told Business Insider, “especially when that means that you’re taking the drug out of the hands of people who do need it.”

Trump has repeatedly talked up the potential benefits of chloroquine, an anti-malaria pill that was first approved in the US in 1949, and a much more widely prescribed version called hydroxychloroquine, that are being tested as possible treatments for the coronavirus.

Never miss out on healthcare news. Subscribe to Dispensed, Business Insider’s weekly newsletter on pharma, biotech, and healthcare.

However, there’s no gold-standard clinical evidence to show that either are effective against COVID-19, the disease caused by the coronavirus. Early results from studies in France and China have been promising, but experts and analysts have pointed to flaws and limitations of the studies and have cautioned against drawing broad conclusions, as Business Insider’s Andrew Dunn reported.

People are desperate for a coronavirus treatment

Still, with 1.5 million people infected and no cure or approved medical treatment for the virus, people are desperate for anything that could help. That’s created an environment where confident but misleading claims — like the ones Trump has made — can run rampant, Fazio said.

Read more: The US is sprinting to develop a coronavirus vaccine or treatment. Here’s how 19 top drugmakers are racing to tackle the pandemic.

“One of the tricky things about this situation is there’s lots of stuff that we know we don’t know,” said Fazio, whose research focuses on how people learn new things and how to combat the effects of misinformation.

“The authorities are saying, ‘we just don’t know,'” Fazio said. “So, anyone who has a firm statement, there’s a good chance that they’ll be believed versus experts who have to give this more nuanced, ‘it might be helpful, it might not, we don’t know yet’ type of stance.”

Strong endorsements from high-profile people have real consequences

But strong endorsements from high-profile people like Trump and Tesla CEO Elon Musk are having real consequences. As they’ve amplified anecdotal reports of the drugs having positive results, demand has ramped up so much that the drugs chloroquine and hydroxychloroquine are now in shortage.

That’s a problem for patients who depend on these medications to treat their arthritis or lupus, who are now struggling to fill their prescriptions.

“People rely on this medication,” Erin Fox, a drug-shortage expert and the senior pharmacy director for the University of Utah’s health system, told Business Insider. “They have chronic illnesses, and they really rely on this. Once you’re stable on these therapies, it’s not something that is easy to switch.”

Michael Rea, the CEO of Rx Savings Solution who was previously a pharmacist, said he was most concerned about the panic that could sweep over people in extreme situations like this. 

“Don’t let fear dictate your decisions,” Rea said. “Only use the drug, prescribe the drug, obtain the drug if you truly need it.”

Read more: Everything we know about remdesivir, hydroxychloroquine, and 4 other drugs being tested against the coronavirus

Andrew Dunn contributed reporting.

Read the original article on Business Insider

Lees Meer